Contract notice

Information

Published

Date of dispatch of this notice: 13/06/2019

Expire date: 01/08/2019

External Reference: 2019-232796

TED Reference: 2019/S 113-276862

Contract notice

Contract notice

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

The Adelaide & Meath Hospital, Dublin Incorporating The National Children's Hospital (AMNCH)
N/A
Procurement Sourcing Contracts Division
Dublin 24
Tallaght
IE
Contact person: Stuart O'Connor
Telephone: +353 014142954
Internet address(es):
Main address: https://www.tuh.ie/

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=148757&B=ETENDERS_SIMPLE
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Supply, Delivery, of Traztuzumab Products
Reference number:  TALSOC498
II.1.2)

Main CPV code

33600000  -  Pharmaceutical products
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

The Objective of this project is to appoint a Tenderer/s who has a clear proven ability in the timely and safe supply of Traztuzumab products to the Hospital Pharmacy Department. The successful Tenderer(s) must meet our requirements as outlined in Section 5 - Particular Performance/Functional Specifications Relating to the Tender/Service and associated Traztuzumab product listing.
The proposal must offer value for money.
II.1.5)

Estimated total value

Value excluding VAT: 1500000.00  EUR
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

33600000  -  Pharmaceutical products
II.2.3)

Place of performance

Main site or place of performance:  
Dublin
II.2.4)

Description of the procurement

The Objective of this project is to appoint a Tenderer/s who has a clear proven ability in the timely and safe supply of Traztuzumab products to the Hospital Pharmacy Department. The successful Tenderer(s) must meet our requirements as outlined in Section 5 - Particular Performance/Functional Specifications Relating to the Tender/Service and associated Traztuzumab product listing.
The proposal must offer value for money.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 1500000.00  EUR
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36
This contract is subject to renewal: yes
Description of renewals:  
There is an option to the extend the contract after 36 months for 2 further periods of 12 months
II.2.10)

Information about variants

Variants will be accepted: yes
II.2.11)

Information about options

Options: no
II.2.12)

Information about electronic catalogues

Tenders must be presented in the form of electronic catalogues or include an electronic catalogue
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.2)

Economic and financial standing

Selection criteria as stated in the procurement documents
III.1.3)

Technical and professional ability

Selection criteria as stated in the procurement documents
III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  18/07/2019
Local time:  12:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.6)

Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until:  12/06/2020
IV.2.7)

Conditions for opening of tenders

Date:  18/07/2019
Local time:  12:00

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  no
VI.4)

Procedures for review

VI.4.1)

Review body

High Court
Four Courts Ground Floor (East Wing) Inns Quay Dublin 7
Dublin
D7
IE